Transcription therapy for cancer (Q34290301)

1 August 2017

1 reference

title

Transcription therapy for cancer (English)

1 reference

1 August 2017

Pandolfi PP

1

1 reference

PubMed ID

11420728

1 August 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

1 August 2017

1 reference

1 August 2017

20

1 reference

1 August 2017

24

1 reference

1 August 2017

3116-3127

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1204299

1 August 2017

0 references

cites work

Fusion genes in solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Sequence-specific DNA recognition by polyamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Regulation of gene expression by small molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Histone acetylation in chromatin structure and transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Two critical hits for promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Chromatin opening of DNA satellites by targeted sequence-specific drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Antisense cancer therapy: the state of the science

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Role of the histone deacetylase complex in acute promyelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Oncogenic transcription factors in the human acute leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Activation of gene expression by small molecule transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Gli proteins and Hedgehog signaling: development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Retinoids in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Recognition of the four Watson-Crick base pairs in the DNA minor groove by synthetic ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

Synthetic zinc finger transcription factor action at an endogenous chromosomal site. Activation of the human erythropoietin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

7 January 2021

Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

7 January 2021

The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

7 January 2021

Transcriptional regulation of cellular transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

7 January 2021

Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

7 January 2021

Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204299

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204299

1 reference

PubMed ID

11420728

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

11420728